Effects of repeated 5-HT6 receptor stimulation on BDNF gene expression and cell survival

被引:6
|
作者
de Foubert, Georgina [1 ]
Khundakar, Ahmad A. [2 ]
Zetterstroem, Tyra S. [1 ]
机构
[1] De Montfort Univ, Fac Hlth & Life Sci, Leicester Sch Pharm, Leicester LE1 9BH, Leics, England
[2] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England
基金
英国生物技术与生命科学研究理事会;
关键词
Brain derived neurotrophic factor; BDNF; 5-HT6; receptors; Neurogenesis; Serotonin; Antidepressant drugs; ANTIDEPRESSANT DRUG-TREATMENT; NEUROTROPHIC FACTOR; RAT-BRAIN; ELECTROCONVULSIVE SHOCK; MESSENGER-RNA; HIPPOCAMPUS; DEPRESSION; NEUROGENESIS; PROTEIN; PROLIFERATION;
D O I
10.1016/j.neulet.2013.08.029
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In support of the neurotrophic hypothesis of depression chronic antidepressant drug treatment increases brain-derived neurotrophic factor (bdnf) gene expression and neurogenesis. Regarding 5-HT active drugs, the 5-HT receptor behind these effects remains unidentified. Here we report the effect of repeated 5-HT6-receptor stimulation on bdnf expression and cell survival. The previously reported acute stimulatory action of the selective 5-HT6 agonist LY-586713 on hippocampal bdnf expression was still present following sub-chronic (4 days), but not chronic (14 days), treatment. The effect on 5-HT6-mediated cell survival was also dependent on a similar length of treatment. Hence, our study found no support for a primary effect of 5-HT6 receptors in the mediation of chronic antidepressant drug-induced up-regulation of bdnf expression or neurogenesis. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:211 / 215
页数:5
相关论文
共 50 条
  • [21] Potent and selective 5-HT6 receptor antagonists
    Bromidge, SM
    MEDICINAL CHEMISTRY INTO THE MILLENNIUM, 2001, (264): : 101 - 119
  • [22] Analysis of 5-HT6 and 5-HT7 receptor gene expression in rats showing differences in novelty-seeking behavior
    Ballaz, S. J.
    Akil, H.
    Watson, S. J.
    NEUROSCIENCE, 2007, 147 (02) : 428 - 438
  • [23] Drug discovery targets:: 5-HT6 receptor
    Davies, SL
    Silvestre, JS
    Guitart, X
    DRUGS OF THE FUTURE, 2005, 30 (05) : 479 - 495
  • [24] Therapeutic Potential of 5-HT6 Receptor Agonists
    Karila, Delphine
    Freret, Thomas
    Bouet, Valentine
    Boulouard, Michel
    Dallemagne, Patrick
    Rochais, Christophe
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (20) : 7901 - 7912
  • [25] Pharmacomodulation of a sulfamide 5-HT6 receptor ligand
    Renault, J
    Bernard, A
    Brajeul, S
    Verhaeghe, P
    Butt, S
    Fabis, F
    Dauphin, F
    Uriac, P
    Rault, S
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2004, 19 (06) : 577 - 583
  • [26] Benzenesulfonyl and Benzenesulfonamide as Modulators of the 5-HT6 Receptor
    Rosse, Gerard
    ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (11): : 881 - 882
  • [27] The putative 5-ht6 receptor:: Localization and function
    Sleight, AJ
    Boess, FG
    Bös, M
    Bourson, A
    ADVANCES IN SEROTONIN RECEPTOR RESEARCH: MOLECULAR BIOLOGY, SIGNAL TRANSDUCTION, AND THERAPEUTICS, 1998, 861 : 91 - 96
  • [28] 5-HT6 RECEPTOR LIGANDS AS ANTIDEMENTIA DRUGS
    Mitchell, Ellen Siobhan
    PHARMACOLOGY OF 5-HT6 RECEPTORS, PT II, 2011, 96 : 163 - 187
  • [29] 5-HT6 RECEPTOR LIGANDS AND THEIR ANTIPSYCHOTIC POTENTIAL
    Arnt, Jorn
    Olsen, Christina Kurre
    PHARMACOLOGY OF 5-HT6 RECEPTORS, PT II, 2011, 96 : 141 - 161
  • [30] The 5-ht6 receptor: Potential CNS functions
    Fone, KCF
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 : U48 - U48